ResultsIQ › Latest results › Hikal Limited
Hikal Limited Q2 FY27 results deck summary
NSE: HIKAL · BSE: 524735
Results deck of 3 Nov 2026, summarised by AI from the filing.
Hikal's Q2 FY27 consolidated revenue rose 36% to ₹434 cr with EBITDA of ₹45 cr at 10.3%, and full-year mid-teens revenue growth guidance was reiterated.
Key takeaways
- Q2 recovery Consolidated revenue ₹434 cr (Q2 FY26: ₹319 cr, +36%) and EBITDA ₹45 cr at 10.3% margin, with PAT ₹(6) cr.
- Full-year guidance Management reiterated full-year guidance of mid teens revenue growth and a substantial improvement in profitability.
- Pharma share Pharmaceuticals rose to 64% of consolidated revenue in Q2 FY27 from 59% in Q2 FY26.
- Pharma driver Pharmaceuticals revenue grew 47% YoY to ₹278 cr on API volume recovery and CDMO execution across the US, Europe and Japan.
- Crop pressure Crop Protection margins were impacted by elevated raw material prices, Chinese competition and deferred demand.
Hikal Limited Q2 FY27 results
As filed: Revenue ₹434 cr (+36% year on year), EBITDA ₹44.9 cr (+300% year on year), PAT −₹6.1 cr, EBITDA margin 10.3% (+815 bps).
The Q2 FY27 score, against the company's own trend, is for premium members.
Earlier results and the share price after them
- Q1 FY27: Revenue ₹403 cr (+6% year on year), EBITDA ₹37.0 cr (+48% year on year), PAT −₹7.4 cr, EBITDA margin 9.2% (+261 bps). Score 45 of 100, In line with trend. Revenue growth was above the company's own trend; EBITDA growth was well above it. EBITDA margin rose 261 bps year on year. Revenue fell 22% from last quarter. Share price after the results: −4.4% in 29 days (Nifty 500: −2.0%).
- Q4 FY26: Revenue ₹519 cr (−6% year on year), EBITDA ₹105 cr (−14% year on year), PAT ₹14.4 cr (−19% year on year), EBITDA margin 20.3% (−199 bps). Score 30 of 100, Below trend. Revenue and EBITDA growth were below the company's own trend; profit before exceptional items growth was in line with it. EBITDA margin fell 199 bps year on year. Other income 80% of PBT. Tax rate -73%. Share price after the results: −2.9% in 29 days (Nifty 500: +0.6%).
- Q3 FY26: Revenue ₹494 cr (+10% year on year), EBITDA ₹82.7 cr (+15% year on year), PAT −₹5.9 cr (+20% year on year), EBITDA margin 16.7% (+66 bps). Score 75 of 100, Above trend. Revenue and EBITDA growth were above the company's own trend; profit before exceptional items growth was in line with it. EBITDA margin rose 66 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −9.6% in 30 days (Nifty 500: −10.1%).
- Q2 FY26: Revenue ₹319 cr (−30% year on year), EBITDA ₹7.0 cr (−91% year on year), PAT −₹35.0 cr (−294% year on year), EBITDA margin 2.2% (−1,000 bps). Score 5 of 100, Below trend. Revenue, EBITDA and profit growth were well below the company's own trend. EBITDA margin fell 1000 bps year on year. Revenue fell 16% from last quarter. Share price after the results: +5.1% in 29 days (Nifty 500: −0.4%).
- Q1 FY26: Revenue ₹380 cr (−7% year on year), EBITDA ₹25.0 cr (−57% year on year), PAT −₹22.0 cr (−300% year on year), EBITDA margin 6.6% (−767 bps). Score 12 of 100, Below trend. Revenue growth was below the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 767 bps year on year. Revenue fell 31% from last quarter. Share price after the results: −14.8% in 29 days (Nifty 500: +0.7%).
- Q4 FY25: Revenue ₹552 cr (+7% year on year), EBITDA ₹123 cr (+31% year on year), PAT ₹50.0 cr (+47% year on year), EBITDA margin 22.3% (+399 bps). Score 86 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA and profit growth were well above it. EBITDA margin rose 399 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −7.8% in 30 days (Nifty 500: +2.5%).
- Q3 FY25: Revenue ₹448 cr (0% year on year), EBITDA ₹72.0 cr (+11% year on year), PAT ₹17.0 cr (+6% year on year), EBITDA margin 16.1% (+156 bps). Score 51 of 100, In line with trend. Revenue, EBITDA and profit growth were in line with the company's own trend. EBITDA margin rose 156 bps year on year. Profit fell 6% from last quarter.
Past price moves after results do not indicate future moves. Not a recommendation.
Hikal Limited earnings call, investor presentation and press release summaries
- Q2 FY27: Earnings call (3 Nov 2026), Results deck (3 Nov 2026), Results press release (3 Nov 2026)
- Q1 FY27: Earnings call (6 Aug 2026), Results deck (6 Aug 2026), Results press release (6 Aug 2026)
- Q4 FY26: Earnings call (27 May 2026), Results deck (27 May 2026)
- Q3 FY26: Earnings call (11 Feb 2026), Results deck (11 Feb 2026)
- Q2 FY26: Earnings call (13 Nov 2025), Results deck (13 Nov 2025), Results press release (13 Nov 2025)
- Q1 FY26: Earnings call (7 Aug 2025), Results deck (7 Aug 2025), Results deck (23 Sep 2025), Results press release (7 Aug 2025)
- Q4 FY25: Earnings call (14 May 2025), Results deck (14 May 2025), Results press release (14 May 2025)
Figures from the company's filings with NSE and BSE. Not investment advice.